A relentless visionary, Robin Kumoluyi consistently moves people and organizations forward. Throughout her career, she has expertly crafted complex quality management strategies for multi-billion-dollar matrixed organizations. Committed to the belief that patients and customers must have access to effective medicine, Robin intentionally chose the quality function within the pharmaceutical industry.
Robin Kumoluyi is the Vice President and Chief Quality Officer, Pharmaceuticals at Johnson & Johnson Corporation. Robin has responsibility for Quality & Compliance for the Global Pharmaceuticals Segment in Pre-Market R&D, Supply Chain and Post Market Commercial. Prior to her current role, Robin was VP, Global Quality Services at Johnson & Johnson, where she drove the organization's Enterprise Quality transformation by defining, leading, and executing the strategic direction and oversight of the Quality Policies, Standards, Digital Healthcare, Innovation and Analytics, Value Chain Quality, and the overall Q&C Strategy and associated processes.
Her proven track record spans thirty years of robust experience leading change while holding senior leadership roles within Quality, R&D, and Manufacturing Compliance in the pharmaceutical and food industries. Her broad expertise encompasses a wide portfolio of product types including OTC, Biological, Pharmaceutical, Devices, Veterinarian, Nutraceuticals, and Food and Beverage products.
Robin is a transformative leader who can steadily garner followership. Her keen ability to co-create for best outcomes led to the successful results in complex start-up and turn-around situations such as new operations, consent decrees, and warning letter remediations.
As a leader, Robin knows it is her responsibility to enable people to achieve their fullest potential. She is committed to the well-being of her colleagues, peers, and community, actively collaborating with people and teams in the name of career growth and progress. She is a champion for diversity and inclusion, which she knows fosters innovation and drives business success. Steadfast in the belief that what is good for the person is good for the organization, she fully embraces her role as a guide and coach and considers it the most rewarding part of her work. She actively engages with industry and leadership organizations such as ISPE (Women in Pharma), PDA, and Rx360, where she was co-leader of the audit operations group.